Related Experiment Videos
Some properties of mouse platelets
Abstract:
Mouse platelets were aggregated by arachidonate, thrombin, collagen and ADP. In general they were, like rat platelets, more aggregative in heparinized PRP than in citrated (3.8%) PRP. Mouse platelets underwent the release reaction when aggregated by arachidonate, collagen and thrombin, but not when stimulated by ADP. The aggregation of the platelets to arachidonate was inhibited by cyclooxygenase inhibitors and by prostacyclin. Studies with tritiated arachidonate showed that mouse platelets possess the lipoxygenase and cyclooxygenase pathways found in other mammalian platelets and produce thromboxane and 12-HETE. The mouse provides a convenient model for the study of many conditions known to affect platelet aggregation. The similarity of mouse platelets to the platelets of other mammals together with the ability to study large numbers of animals at low cost, should encourage further use of mouse platelets.
Insights
Mouse platelets aggregate similarly to other mammals, responding to various agonists and undergoing the release reaction. Their pathways for arachidonate metabolism make them a valuable, cost-effective model for platelet aggregation studies.
Area of Science:
- Hematology
- Pharmacology
- Biomedical Research
Background:
- Platelet aggregation is crucial for hemostasis and thrombosis.
- Understanding mammalian platelet function is vital for cardiovascular research.
- The mouse is increasingly used as a model organism in biomedical studies.
Purpose of the Study:
- To characterize the aggregation and release reactions of mouse platelets.
- To investigate the metabolic pathways involved in mouse platelet activation.
- To evaluate the suitability of mouse platelets as a model for platelet research.
Main Methods:
- Platelet-rich plasma (PRP) from mice was prepared and tested for aggregation.
- Aggregation was induced using agonists like arachidonate, thrombin, collagen, and ADP.
- The effects of cyclooxygenase inhibitors and prostacyclin on aggregation were assessed.
- Metabolic studies utilized tritiated arachidonate to identify pathway activity.
Main Results:
- Mouse platelets showed higher aggregation in heparinized PRP compared to citrated PRP.
- Platelets underwent a release reaction with arachidonate, thrombin, and collagen, but not ADP.
- Arachidonate-induced aggregation was inhibited by cyclooxygenase inhibitors and prostacyclin.
- Mouse platelets possess both lipoxygenase and cyclooxygenase pathways, producing thromboxane and 12-HETE.
Conclusions:
- Mouse platelets exhibit aggregation and release characteristics similar to other mammals.
- The identified metabolic pathways (cyclooxygenase and lipoxygenase) are conserved.
- The mouse is a cost-effective and convenient model for studying platelet aggregation and related conditions.